A previous study was able to demonstrate that disruption of the transport metabolon with an antibody, targeted against the CAIX-binding site in CD147, reduces proton-coupled lactate transport and inhibits proliferation of breast cancer cells under hypoxia [12]. The gene discussed is CA9; the disease is breast carcinoma.